•First-line management of HFpEF includes sodium-glucose cotransporter type 2 (SGLT2) inhibitors, diuretics and treatment of coexisting comorbidities such as hypertension and diabetes. This evidence concerns the gene SLC5A2 and diabetes mellitus.